Merck Greeher to become CEO of Sanofi

On February 12, Sanofi announced that the board of directors has appointed Belén Garijo as the CEO of Sanofi, effective after the conclusion of the group’s annual general meeting on April 29, 2026; she will no longer serve on the board alongside Paul Hudson, whose tenure as CEO will officially end on February 17, 2026. Belén Garijo has been the CEO of Merck since 2021. Last year, Merck Group announced that Garijo would complete her term as planned by the end of April 2026. (Yicai)

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)